tiprankstipranks
BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF

BioVaxys Technology (BVAXF) Financial Statements

29 Followers

BioVaxys Technology Financial Overview

BioVaxys Technology's market cap is currently ―. The company's EPS TTM is $-0.081; its P/E ratio is -0.70; BioVaxys Technology is scheduled to report earnings on June 27, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 23Apr 23Jan 23Oct 22Jul 22
Income Statement-
Total Revenue---C$ 0.00C$ 0.00
Gross Profit-----
EBITC$ -1.58MC$ -1.49MC$ -959.10KC$ -923.96KC$ -909.43K
EBITDAC$ -1.58MC$ -1.49M-C$ -923.96KC$ -909.43K
Net Income Common StockholdersC$ -1.58MC$ -1.49MC$ -956.04KC$ -8.55MC$ -912.17K
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 423.00C$ 28.48KC$ 71.61KC$ 141.90KC$ 39.05K
Total AssetsC$ 1.41MC$ 2.65MC$ 1.26MC$ 865.56KC$ 7.89M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -423.00C$ -28.48KC$ -71.61KC$ -141.90KC$ -39.05K
Total LiabilitiesC$ 2.04MC$ 1.76MC$ 1.88MC$ 1.64MC$ 1.69M
Stockholders EquityC$ -624.21KC$ 897.57KC$ -616.73KC$ -773.53KC$ 6.20M
Cash Flow-
Free Cash FlowC$ -23.74KC$ -711.83KC$ -317.25KC$ -209.02KC$ -75.79K
Operating Cash FlowC$ -23.74KC$ -711.83KC$ -317.25KC$ -209.02KC$ -75.79K
Investing Cash Flow-----
Financing Cash Flow-C$ 670.00KC$ 247.10KC$ 328.60KC$ 0.00
Currency in CAD

BioVaxys Technology Earnings and Revenue History

BioVaxys Technology Debt to Assets

BioVaxys Technology Cash Flow

BioVaxys Technology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis